Announcements

Welcome to the Chinese edition of Translational Lung Cancer Research (TLCR)

Published: 2022-09-08

We are glad to share with you that select TLCR content is now available in Chinese: https://tlcr.amegroups.com/post/category/tlcr-chinese-edition.

The TLCR Chinese edition (the Chinese edition of Frontiers of Translational Lung Cancer Research) is a Chinese-language column that addresses the growing need for trusted medical information in China. The initiative of the TLCR Chinese edition aims to raise awareness of medical advances among clinicians through translated content, enhancing the links between Chinese scientists and the international medical community.

The translation of a selection of full-text content from TLCR applies rigorous standards to ensure accuracy and quality control. The TLCR Chinese edition will deliver the quality clinical and scientific content to the Chinese medical and clinical research community.

Access to the TLCR Chinese edition includes:

1. Access via Article options.



2. Access via the TLCR Chinese edition button of the home page.